+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alzheimer Diagnostic Tests - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 315 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5505015
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's Medical Devices sector report, “Alzheimer Diagnostic Tests - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Alzheimer Diagnostic Tests are test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Alzheimer Overview
3 Products under Development
3.1 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Alzheimer Diagnostic Tests - Pipeline Products by Territory
3.3 Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Alzheimer Diagnostic Tests - Ongoing Clinical Trials
4 Alzheimer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Alzheimer Companies - Pipeline Products by Stage of Development
4.2 Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development
5 Alzheimer Companies and Product Overview6 Alzheimer- Recent Developments
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
List of Tables
Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development
Alzheimer Diagnostic Tests - Pipeline Products by Territory
Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path
Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Alzheimer Diagnostic Tests - Ongoing Clinical Trials
Alzheimer Companies - Pipeline Products by Stage of Development
Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development
Glossary
List of Figures
Alzheimer Diagnostic Tests - Pipeline Products by Stage of Development
Alzheimer Diagnostic Tests - Pipeline Products by Territory
Alzheimer Diagnostic Tests - Pipeline Products by Regulatory Path
Alzheimer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Alzheimer Diagnostic Tests - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 5M Biomed LLC
  • AC Immune SA
  • Acobiom
  • Acumen Pharmaceuticals Inc
  • Adlyfe Inc
  • Admit Therapeutics SL
  • ADx NeuroSciences NV
  • Aelan Cell Technologies
  • Agent Biotech
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Alzheon Inc
  • Alzhyme Pty Ltd
  • Alzinova AB
  • Amarantus Bioscience Holdings Inc
  • Amarantus Diagnostics Inc
  • Ambergen Inc
  • Amco International Manufacturing Inc.
  • Amoneta Diagnostics SAS
  • Amprion Inc
  • Applied NeuroSolutions, Inc. (Inactive)
  • Arkley Biotek LLC
  • Ascent Bio-Nano Technologies Inc
  • attyloid GmbH
  • Banyan Biomarkers Inc
  • BioArctic AB
  • Bioasis Technologies Inc
  • Biocross SL
  • Biomedical Development Corp
  • Biorchestra Co Ltd
  • BioSystems International
  • Boston University Medical Campus
  • Brigham and Women's Hospital
  • C2N Diagnostics LLC
  • Calviri Inc
  • Cassava Sciences Inc
  • Cayman Chemical Co
  • Chronix Biomedical Inc
  • Cleveland Diagnostics Inc.
  • Cognext Diagnostics LLC
  • Columbia University
  • Cymedx
  • Cytox Ltd
  • Diadem SRL
  • DiamiR LLC
  • DiaPat GmbH
  • Durin Technologies, Inc.
  • Emory University
  • Eurobio Scientific SA
  • Florida Institute of Technology
  • French National Institute of Health and Medical Research
  • Fujirebio Diagnostics Inc
  • GenoScreen SAS
  • Ghent University
  • IBM Research-Australia
  • ICDD-sas
  • Inbiomed
  • Innovative Health Diagnostics
  • Instituto de Estructura de la Materia
  • Integrated Diagnostics Inc (Inactive)
  • Intelligent OMICS Ltd
  • Janssen Pharmaceutica NV
  • Johns Hopkins University
  • Johns Hopkins University School of Medicine
  • KineMed Inc
  • King's College London
  • Lund University
  • McGill University Health Center
  • Medifron DBT Inc
  • Memory Dx LLC
  • Meso Scale Diagnostics LLC
  • Michigan State University
  • Myriad RBM Inc
  • NanoSomiX Inc
  • Nanosphere Inc (Inactive)
  • National Research Foundation of Korea
  • National University of Singapore
  • Nel ASA
  • NeoNeuro SAS
  • Neuro Bio Ltd
  • NeuroQuest Ltd
  • NeuroVision Imaging LLC
  • Newcastle University
  • Novel Bio-spectrum Technologies Inc (Inactive)
  • Oligomerix inc
  • Orasi Medical, Inc. (Inactive)
  • Oryzon Genomics SA
  • Peri Rx Inc
  • Pre Diagnostics AS
  • Predemtec GmbH
  • ProMIS Neurosciences Inc
  • Proplex Technologies Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomics International Laboratories Ltd
  • Quanterix Corp
  • Redox Diagnostics LLC
  • Roche Diagnostics GmbH
  • Roche Diagnostics International Ltd
  • Rockefeller University
  • Ruhr-University Bochum
  • Scout Diagnostics LLC
  • Seer Biosciences Inc
  • Siemens Healthineers AG
  • StageZero Life Sciences Ltd
  • Sugentech Inc
  • Synaptogenix, Inc.
  • TauRx Pharmaceuticals Ltd
  • The Florey Institute of Neuroscience and Mental Health
  • The Hong Kong University of Science and Technology
  • The University of Nottingham
  • TopoGEN Inc
  • Trinity College Dublin
  • True Diagnostics Inc
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Chicago
  • University of Georgia
  • University of Gottingen
  • University of Illinois at Chicago
  • University of Luxembourg
  • University of Maryland Baltimore
  • University of Melbourne
  • University of Oxford
  • University of Pittsburgh
  • University of South Carolina
  • University of South Florida
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center
  • Urvogelbio Pvt Ltd
  • US Biomarkers Inc
  • vall d hebron institut de Recerca
  • Veravas Inc
  • Virtici LLC
  • Vitruvian Biomedical Inc
  • Washington University in St Louis
  • Washington University School of Medicine
  • Zoiray Technologies Inc.